Botulinum Toxin to Improve Results in Cleft Lip Repair: A Double-Blinded, Randomized, Vehicle-Controlled Clinical Trial
Open Access
- 26 December 2014
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (12), e115690
- https://doi.org/10.1371/journal.pone.0115690
Abstract
Most patients with facial scarring would value even a slight improvement in scar quality. Botulinum toxin A is widely used to alleviate facial dynamic rhytides but is also believed to improve scar quality by reducing wound tension during healing. The main objective was to assess the effect of Botulinum toxin on scars resultant from standardized upper lip wounds. In this double-blinded, randomized, vehicle-controlled, prospective clinical trial, 60 consecutive consenting adults undergoing cleft lip scar revision (CLSR) surgery between July 2010 and March 2012 were randomized to receive botulinum toxin A (n = 30) or vehicle (normal saline; n = 30) injections into the subjacent orbicularis oris muscle immediately after wound closure. Scars were independently assessed at 6-months follow-up in blinded fashion using: Vancouver Scar Scale (VSS), Visual Analogue Scale (VAS) and photographic plus ultrasound measurements of scar widths. 58 patients completed the trial. All scar assessment modalities revealed statistically significantly better scars in the experimental than the vehicle-control group. Quality of surgical upper lip scars, which are oriented perpendicular to the direction of pull of the underlying orbicularis oris muscle, is significantly improved by its temporary paralysis during wound healing. ClinicalTrials.gov NCT01429402Keywords
This publication has 22 references indexed in Scilit:
- Current Methods Employed in the Prevention and Minimization of Surgical ScarsDermatologic Surgery, 2011
- Improving Cutaneous Scar Formation by Controlling the Mechanical EnvironmentAnnals of Surgery, 2011
- Screening for Psychiatric Problems in the Orofacial Trauma SettingOral and Maxillofacial Surgery Clinics of North America, 2010
- Use of Intraoperative Botulinum Toxin in Facial ReconstructionDermatologic Surgery, 2009
- Effect of Botulinum Toxin Type A on a Rat Surgical Wound ModelClinical and Experimental Otorhinolaryngology, 2009
- Keloid and hypertrophic scarring may result from a mechanoreceptor or mechanosensitive nociceptor disorderMedical Hypotheses, 2008
- Botulinum Toxin to Improve Facial Wound Healing: A Prospective, Blinded, Placebo-Controlled StudyMayo Clinic Proceedings, 2006
- Anxiety and self‐consciousness in patients with minor facial lacerationsJournal of Advanced Nursing, 2004
- Botulinum Toxin to Minimize Facial ScarringFacial Plastic Surgery, 2002
- AESTHETIC INDICATIONS FOR BOTULINUM TOXIN INJECTIONSPlastic and Reconstructive Surgery, 1995